Method for testing the differentiation status in pancreatic cells of a mammal
Patent Number: 5948623
Date of First Priority Issue: Tuesday December 31st, 1996
Date Issued: Tuesday September 7th, 1999
Assignee: Max-Planck Gesellschaft Zur Forderung der Wissenschaften E.V. (Berlin, DE)
Inventors: Sosa-Pineda, Beatriz (Memphis, TN); Gruss, Peter (Gottingen, DE)
From Class: Differentiation
Comments: No comments
This patent covers the use of the transcription factor Pax4 for identifying the number of pancreatic stem cells in an animal. This patent is useful for entities seeking to expand the number of pancreatic stem cells in vivo through administration of various compounds. One such example is the work by Transition Therapeutics utilizing gastrin with EGF for treatment of diabetes through inducing proliferation of endogenous pancreatic stem cells in vivo.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.